Step Therapy Criteria 2019

Similar documents
ALLERGIC RHINITIS-NASAL

Step Therapy Criteria (Criteria for Step Therapy-2 [ST-2] Drugs)

Step Therapy Requirements

Step Therapy Requirements. Effective: 05/01/2018

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

Step Therapy Requirements

Step Therapy Requirements. Effective: 11/01/2018

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

ANGIOTENSIN RECEPTOR BLOCKERS

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

2017 Step Therapy Criteria

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Step Therapy Requirements. Effective: 1/1/2019

Quarterly pharmacy formulary change notice

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS

2018 Step Therapy Criteria

ANTICONVULSANTS. Details

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

ANTIDIABETIC AGENTS - MISCELLANEOUS

Step Therapy Group Algorithm Steps

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

FirstCarolinaCare Insurance Company Step Therapy Requirements

ADHD STIMULANTS-S(SHC)

Beneficiary Advisory Panel Handout Uniform Formulary Decisions 23 June 2011

Step Therapy Group. Atypical Antipsychotic Agents

DPP4 INHIBITORS. Products Affected Step 2: Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet

BLUE SHIELD OF CALIFORNIA MARCH 2016 STANDARD DRUG FORMULARY CHANGES

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

2018 Step Therapy Criteria (List of Step Therapy Criteria)

FirstCarolinaCare Insurance Company. Step Therapy Requirements

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

ATYPICAL ANTIPSYCHOTICS

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

2018 Step Therapy Criteria (List of Step Therapy Criteria)

DPP4 INHIBITORS. Details. Step Therapy Criteria Health Alliance Plan 2019 Date Effective: 04/01/2019

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

Save on your drugs with HealthyRx

ALLERGIC CONJUNCTIVITIS AGENTS

Medication Policy Manual. Topic: Dupixent, dupilumab Date of Origin: March 10, Committee Approval: March 10, 2017 Next Review Date: May 2018

Eucrisa. Eucrisa (crisaborole) Description

2018 Step Therapy (ST) Criteria

2017 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

ANTIDEPRESSANTS - BUPROPION

Simply Step Therapy Document September 2018 Y0114_18_33074_I_009

Eucrisa. Eucrisa (crisaborole) Description

Effective for all members on August 1, 2017

Quarterly Pharmacy Formulary Change Notice

Neighborhood Medicaid Formulary Changes: June 2017

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

Step Therapy Requirements

Product List Finished Dosage Forms (FDF) B2B Business

ANTICONVULSANTS. Details

TEST ANTICONVULSANT THERAPY. Products Affected. Step 2: Network Health Insurance Corporation NetworkCares Step Therapy Criteria Last Updated 11/2018

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

Premium Step Therapy. Here s how it works:

These medications will require preauthorization (PA) for HMSA Medicare Part D members.

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

Step Therapy Medications

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Introducing exciting new Rx benefits 2019

2017 Formulary Changes Year to Date

ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017

ANTICONVULSANT STEP THERAPY

DIABETES (1 of 5) Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10. Generic. Generic $0 $5 $5-10 $0 $0 $0. Generic $0 $5 $5-10 $0 $0 $0

The safety and effectiveness of Dupixent in pediatric patients have not been established (1).

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

SelectHealth Advantage 2018 Step Therapy Criteria. Previous trial on at least ONE: Generic topical acne treatment. Previous trial on: alendronate

Oregon Health Plan prescription benefit updates

Objectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia)

Fee-for-Service Pharmacy Provider Notice #216 ** March 2016 PDL Changes ** Existing Drug Classes

ANTICONVULSANT THERAPY

Pharmacologic Agents for Treatment of Type 2 Diabetes

Step Therapy Requirements. Effective: 12/01/2016

PHARMA-MEDIC SERVICES INC. POLICY MANUAL

Drugs requiring prior authorization: the list of drugs requiring prior authorization for this clinical criteria

Transcription:

Step Therapy 2019 For information on obtaining an updated coverage determination or an exception to a coverage determination please call Freedom Health Member Services at 1-800-401-2740 or, for TTY/TDD users 711. Our hours are October 1 to March 31 from 8:00 am to 8:00 pm EST 7 days a week and April 1 to September 30 from 8:00 am to 8:00 pm EST Monday through Friday or visit www.freedomhealth.com. For an indexed list of drugs please go to page 13. Last updated 10/1/2018

anti-emetics hrm PHENADOZ SUPPOSITORY 12.5 MG RECTAL promethazine hcl suppository 12.5 mg rectal promethazine hcl suppository 25 mg rectal promethazine hcl suppository 50 mg rectal promethazine hcl syrup 6.25 mg/5ml oral promethazine hcl tablet 12.5 mg oral promethazine hcl tablet 25 mg oral promethazine hcl tablet 50 mg oral PROMETHEGAN SUPPOSITORY 25 MG RECTAL PROMETHEGAN SUPPOSITORY 50 MG RECTAL trimethobenzamide hcl capsule 300 mg oral ANY ONE OF THE FOLLOWING DRUGS IN THE PREVIOUS 180 DAYS BEFORE MOVING TO STEP 2: Ondansetron, Granisetron. Step 2: Promethazine, Phenadoz, Promethagan, Trimethobenzamide. only applies for a diagnosis of nausea and vomiting. does not apply to the diagnosis of motion sickness. Step therapy only applies to members 65 years of age or older 1

anxiolytics hrm meprobamate tablet 200 mg oral meprobamate tablet 400 mg oral ANY ONE OF THE FOLLOWING DRUGS IN THE PREVIOUS 180 DAYS BEFORE MOVING TO STEP 2: Buspirone. Step 2: Meprobamate Step therapy only applies to members 65 years of age or older 2

atypicals FANAPT TABLET 1 MG ORAL FANAPT TABLET 10 MG ORAL FANAPT TABLET 12 MG ORAL FANAPT TABLET 2 MG ORAL FANAPT TABLET 4 MG ORAL FANAPT TABLET 6 MG ORAL FANAPT TABLET 8 MG ORAL FANAPT TITRATION PACK TABLET 1 & 2 & 4 & 6 MG ORAL INVEGA SUSTENNA SUSPENSION 117 MG/0.75ML INTRAMUSCULAR INVEGA SUSTENNA SUSPENSION 156 MG/ML INTRAMUSCULAR INVEGA SUSTENNA SUSPENSION 234 MG/1.5ML INTRAMUSCULAR INVEGA SUSTENNA SUSPENSION 39 MG/0.25ML INTRAMUSCULAR INVEGA SUSTENNA SUSPENSION 78 MG/0.5ML INTRAMUSCULAR INVEGA TRINZA SUSPENSION 273 MG/0.875ML INTRAMUSCULAR INVEGA TRINZA SUSPENSION 410 MG/1.315ML INTRAMUSCULAR INVEGA TRINZA SUSPENSION 546 MG/1.75ML INTRAMUSCULAR INVEGA TRINZA SUSPENSION 819 MG/2.625ML INTRAMUSCULAR LATUDA TABLET 120 MG ORAL LATUDA TABLET 20 MG ORAL LATUDA TABLET 40 MG ORAL LATUDA TABLET 60 MG ORAL LATUDA TABLET 80 MG ORAL REXULTI TABLET 0.25 MG ORAL REXULTI TABLET 0.5 MG ORAL REXULTI TABLET 1 MG ORAL REXULTI TABLET 2 MG ORAL REXULTI TABLET 3 MG ORAL REXULTI TABLET 4 MG ORAL RISPERDAL CONSTA SUSPENSION RECONSTITUTED 12.5 MG INTRAMUSCULAR RISPERDAL CONSTA SUSPENSION RECONSTITUTED 25 MG INTRAMUSCULAR RISPERDAL CONSTA SUSPENSION RECONSTITUTED 37.5 MG INTRAMUSCULAR RISPERDAL CONSTA SUSPENSION RECONSTITUTED 50 MG INTRAMUSCULAR SAPHRIS TABLET SUBLINGUAL 10 MG SUBLINGUAL SAPHRIS TABLET SUBLINGUAL 2.5 MG SUBLINGUAL SAPHRIS TABLET SUBLINGUAL 5 MG SUBLINGUAL TWO OF THE FOLLOWING DRUGS IN THE PREVIOUS 180 DAYS BEFORE MOVING TO STEP 2: aripiprazole, clozapine, risperidone, olanzapine, paliperidone, quetiapine, ziprasidone. Step 2: Fanapt, Invega Sustenna, Invega Trinza, Latuda, Rexulti, Risperdal Consta, Saphris. Step Therapy only applies to new starts only. Enrollees stabilized on medication will not be required to go through step therapy. Step therpay criteria only applies for the diagnosis of schizophrenia. 3

diabetes AVANDIA TABLET 2 MG ORAL AVANDIA TABLET 4 MG ORAL ANY TWO OF THE FOLLOWING DRUGS IN THE PREVIOUS 180 DAYS BEFORE MOVING TO STEP 2: Acarbose, Basaglar, Glimepiride, Glipizide, Glipizide ER, Glipizide XL, Glipizide/Metformin Hcl, Humalog, Humalog Mix 50/50, Humalog Mix 75/25, Humulin 70/30, Humulin N, Humulin R, Lantus, Lantus Solostar, Levemir, Levemir Flexpen, Metformin Hcl, Metformin Hcl Er, Nateglinide, Novolog, Novolog Flexpen, Novolog Mix 70/30, Novolin N, Novolin R, Novolin 70/30, Pioglitazone/Metformin, Repaglinide, Toujeo, Tresiba Step 2: Avandia. 4

dpp-4 inhibitors JANUMET TABLET 50-1000 MG ORAL JANUMET TABLET 50-500 MG ORAL JANUMET XR TABLET EXTENDED RELEASE 24 HOUR 100-1000 MG ORAL JANUMET XR TABLET EXTENDED RELEASE 24 HOUR 50-1000 MG ORAL JANUMET XR TABLET EXTENDED RELEASE 24 HOUR 50-500 MG ORAL JANUVIA TABLET 100 MG ORAL JANUVIA TABLET 25 MG ORAL JANUVIA TABLET 50 MG ORAL KOMBIGLYZE XR TABLET EXTENDED RELEASE 24 HOUR 2.5-1000 MG ORAL KOMBIGLYZE XR TABLET EXTENDED RELEASE 24 HOUR 5-1000 MG ORAL KOMBIGLYZE XR TABLET EXTENDED RELEASE 24 HOUR 5-500 MG ORAL ONGLYZA TABLET 2.5 MG ORAL ONGLYZA TABLET 5 MG ORAL TRADJENTA TABLET 5 MG ORAL ANY TWO OF THE FOLLOWING DRUGS IN THE PREVIOUS 180 DAYS BEFORE MOVING TO STEP 2: Glipizide/Metformin HCL, Metformin HCL, Metformin HCL ER, Pioglitazone/Metformin Step 2: Janumet, Januvia, Onglyza, Janumet XR, Kombiglyze, Tradjenta 5

glp1 agonist BYETTA 10 MCG PEN SOLUTION PEN- INJECTOR 10 MCG/0.04ML SUBCUTANEOUS BYETTA 5 MCG PEN SOLUTION PEN- INJECTOR 5 MCG/0.02ML SUBCUTANEOUS TANZEUM PEN-INJECTOR 30 MG SUBCUTANEOUS TANZEUM PEN-INJECTOR 50 MG SUBCUTANEOUS VICTOZA SOLUTION PEN-INJECTOR 18 MG/3ML SUBCUTANEOUS ANY TWO OF THE FOLLOWING DRUGS IN THE PREVIOUS 180 DAYS BEFORE MOVING TO STEP 2: Acarbose, Glimepiride, Glipizide, Glipizide ER, Glipizide XL, Glipizide/Metformin HCL, Metformin HCL, Metformin HCL ER, Pioglitazone/Metformin, Nateglinide, Repaglinide. Step 2: Tanzeum, Victoza, Byetta 6

non-sedating antihistamines CLARINEX-D 12 HOUR TABLET EXTENDED RELEASE 12 HOUR 2.5-120 MG ORAL desloratadine tablet 5 mg oral desloratadine tablet dispersible 2.5 mg oral desloratadine tablet dispersible 5 mg oral ANY TWO OF THE FOLLOWING DRUGS IN THE PREVIOUS 180 DAYS BEFORE MOVING TO STEP 2: Allegra OTC, Allegra D OTC, Loratadine OTC, Loratadine D OTC, Cetirizine OTC, Cetirizine D OTC, Levocetirizine 0.5mg/ml oral soln., Levocetirizine 5mg OTC: Step 2: Desloratadine, Clarinex D. Only one drug, cetirizine, is required to be tried for the diagnosis of perennial allergic rhinitis. 7

ppi lansoprazole tablet dispersible 15 mg oral lansoprazole tablet dispersible 30 mg oral ANY TWO OF THE FOLLOWING DRUGS IN THE PREVIOUS 180 DAYS BEFORE MOVING TO STEP 2: lansoprazole, lansoprazole OTC, Priolosec Otc, Nexium OTC, Omeprazole Otc, Omeprazole, Pantoprazole, Rabeprazole, Prevacid OTC, Zegerid OTC. Step 2: lansoprazole Solutabs.For the diagnosis of risk reduction of NSAID associated gastric ulcer only lansoprazole is required. 8

renin inhibitors TEKTURNA HCT TABLET 150-12.5 MG ORAL TEKTURNA HCT TABLET 150-25 MG ORAL TEKTURNA HCT TABLET 300-12.5 MG ORAL TEKTURNA HCT TABLET 300-25 MG ORAL TEKTURNA TABLET 150 MG ORAL TEKTURNA TABLET 300 MG ORAL ANY TWO OF THE FOLLOWING DRUGS, 1 DRUG FROM EACH CLASS, IN THE PREVIOUS 180 DAYS BEFORE MOVING TO STEP 2: ACE-Inhibitors (including combinations with HCTZ) - Benazepril Hcl, Benazepril Hctz, Captopril, Captopril /Hctz, Enalapril Maleate, Enalapril Maleate/Hctz, Fosinopril Sodium, Fosinopril sodium/hctz, Lisinopril, Lisinopril /Hctz, Quinapril Hcl, Quinipril/HCTZ, Trandolapril, Ramipril. ARBs (including combinations with HCTZ) - Olmasartan, Olmasartan/Hct, losartan, losartan/hct, irbesartan, irbesartan/hctz, valsartan, valsartan/hctz. Step 2: Tekturna, Tekturna Hct 9

symlin SYMLINPEN 120 SOLUTION PEN- INJECTOR 2700 MCG/2.7ML SUBCUTANEOUS SYMLINPEN 60 SOLUTION PEN- INJECTOR 1500 MCG/1.5ML SUBCUTANEOUS ANY TWO OF THE FOLLOWING DRUGS IN THE PREVIOUS 180 DAYS BEFORE MOVING TO STEP 2: Basaglar, Humalog, Humalog Mix 50/50, Humalog Mix 75/25, Humulin 70/30, Humulin N, Humulin R, Lantus, Levemir, Novolog, Novolog Mix 70/30, Novolin R, Novolin N, Novolin 70/30, Toujeo, Tresiba Step 2: Symlin 10

topical_immunomodulators ELIDEL CREAM 1 % EXTERNAL tacrolimus ointment 0.03 % external tacrolimus ointment 0.1 % external ANY TWO OF THE FOLLOWING DRUGS IN THE PREVIOUS 180 DAYS BEFORE MOVING TO STEP 2: Ala-Cort, Alclometasone Dipropionate, Amcinonide, Augmented Betamethasone Dipropionate, Betamethasone, Betamethasone Dipropionate, Betamethasone Valerate, Clobetasol Propionate, Clobetasol Propionate Emollient, Desonide, Desoximetasone, Diflorasone Diacetate, Fluocinolone Acetonide, Fluocinonide, Fluticasone, Halobetasol Propionate, Hydrocortisone Butyrate, Hydrocortisone Valerate, Mometasone Furoate, Prednicarbate, Triamcinolone Acetonide, Triamcinolone Acetonide In Absorbase. Step 2: Elidel, Tacrolimus 11

ULORIC ULORIC TABLET 40 MG ORAL ULORIC TABLET 80 MG ORAL THE FOLLOWING DRUG/S IN THE PREVIOUS 180 DAYS BEFORE MOVING TO STEP 2: Allopurinol. STEP 2: Uloric 12

Index (Índice) AVANDIA TABLET 2 MG ORAL...4 AVANDIA TABLET 4 MG ORAL...4 BYETTA 10 MCG PEN SOLUTION PEN-INJECTOR 10 MCG/0.04ML SUBCUTANEOUS... 6 BYETTA 5 MCG PEN SOLUTION PEN- INJECTOR 5 MCG/0.02ML SUBCUTANEOUS... 6 CLARINEX-D 12 HOUR TABLET EXTENDED RELEASE 12 HOUR 2.5-120 MG ORAL...7 desloratadine tablet 5 mg oral... 7 desloratadine tablet dispersible 2.5 mg oral... 7 desloratadine tablet dispersible 5 mg oral...7 ELIDEL CREAM 1 % EXTERNAL...11 FANAPT TABLET 1 MG ORAL...3 FANAPT TABLET 10 MG ORAL...3 FANAPT TABLET 12 MG ORAL...3 FANAPT TABLET 2 MG ORAL...3 FANAPT TABLET 4 MG ORAL...3 FANAPT TABLET 6 MG ORAL...3 FANAPT TABLET 8 MG ORAL...3 FANAPT TITRATION PACK TABLET 1 & 2 & 4 & 6 MG ORAL... 3 INVEGA SUSTENNA SUSPENSION 117 MG/0.75ML INTRAMUSCULAR... 3 INVEGA SUSTENNA SUSPENSION 156 MG/ML INTRAMUSCULAR... 3 INVEGA SUSTENNA SUSPENSION 234 MG/1.5ML INTRAMUSCULAR... 3 INVEGA SUSTENNA SUSPENSION 39 MG/0.25ML INTRAMUSCULAR... 3 INVEGA SUSTENNA SUSPENSION 78 MG/0.5ML INTRAMUSCULAR... 3 INVEGA TRINZA SUSPENSION 273 MG/0.875ML INTRAMUSCULAR... 3 INVEGA TRINZA SUSPENSION 410 MG/1.315ML INTRAMUSCULAR... 3 INVEGA TRINZA SUSPENSION 546 MG/1.75ML INTRAMUSCULAR... 3 INVEGA TRINZA SUSPENSION 819 MG/2.625ML INTRAMUSCULAR... 3 JANUMET TABLET 50-1000 MG ORAL...5 JANUMET TABLET 50-500 MG ORAL...5 JANUMET XR TABLET EXTENDED RELEASE 24 HOUR 100-1000 MG ORAL... 5 JANUMET XR TABLET EXTENDED RELEASE 24 HOUR 50-1000 MG ORAL...5 JANUMET XR TABLET EXTENDED RELEASE 24 HOUR 50-500 MG ORAL...5 JANUVIA TABLET 100 MG ORAL... 5 JANUVIA TABLET 25 MG ORAL... 5 JANUVIA TABLET 50 MG ORAL... 5 KOMBIGLYZE XR TABLET EXTENDED RELEASE 24 HOUR 2.5-1000 MG ORAL...5 KOMBIGLYZE XR TABLET EXTENDED RELEASE 24 HOUR 5-1000 MG ORAL...5 KOMBIGLYZE XR TABLET EXTENDED RELEASE 24 HOUR 5-500 MG ORAL...5 lansoprazole tablet dispersible 15 mg oral... 8 lansoprazole tablet dispersible 30 mg oral... 8 LATUDA TABLET 120 MG ORAL... 3 LATUDA TABLET 20 MG ORAL... 3 LATUDA TABLET 40 MG ORAL... 3 LATUDA TABLET 60 MG ORAL... 3 LATUDA TABLET 80 MG ORAL... 3 meprobamate tablet 200 mg oral...2 meprobamate tablet 400 mg oral...2 ONGLYZA TABLET 2.5 MG ORAL... 5 ONGLYZA TABLET 5 MG ORAL... 5 PHENADOZ SUPPOSITORY 12.5 MG RECTAL...1 promethazine hcl suppository 12.5 mg rectal...1 promethazine hcl suppository 25 mg rectal...1 promethazine hcl suppository 50 mg rectal...1 promethazine hcl syrup 6.25 mg/5ml oral...1 promethazine hcl tablet 12.5 mg oral...1 promethazine hcl tablet 25 mg oral...1 promethazine hcl tablet 50 mg oral...1 PROMETHEGAN SUPPOSITORY 25 MG RECTAL... 1 PROMETHEGAN SUPPOSITORY 50 MG RECTAL... 1 REXULTI TABLET 0.25 MG ORAL... 3 REXULTI TABLET 0.5 MG ORAL... 3 13

REXULTI TABLET 1 MG ORAL... 3 REXULTI TABLET 2 MG ORAL... 3 REXULTI TABLET 3 MG ORAL... 3 REXULTI TABLET 4 MG ORAL... 3 RISPERDAL CONSTA SUSPENSION RECONSTITUTED 12.5 MG INTRAMUSCULAR...3 RISPERDAL CONSTA SUSPENSION RECONSTITUTED 25 MG INTRAMUSCULAR...3 RISPERDAL CONSTA SUSPENSION RECONSTITUTED 37.5 MG INTRAMUSCULAR...3 RISPERDAL CONSTA SUSPENSION RECONSTITUTED 50 MG INTRAMUSCULAR...3 SAPHRIS TABLET SUBLINGUAL 10 MG SUBLINGUAL... 3 SAPHRIS TABLET SUBLINGUAL 2.5 MG SUBLINGUAL... 3 SAPHRIS TABLET SUBLINGUAL 5 MG SUBLINGUAL...3 SYMLINPEN 120 SOLUTION PEN- INJECTOR 2700 MCG/2.7ML SUBCUTANEOUS... 10 SYMLINPEN 60 SOLUTION PEN- INJECTOR 1500 MCG/1.5ML SUBCUTANEOUS... 10 tacrolimus ointment 0.03 % external...11 tacrolimus ointment 0.1 % external...11 TANZEUM PEN-INJECTOR 30 MG SUBCUTANEOUS... 6 TANZEUM PEN-INJECTOR 50 MG SUBCUTANEOUS... 6 TEKTURNA HCT TABLET 150-12.5 MG ORAL... 9 TEKTURNA HCT TABLET 150-25 MG ORAL... 9 TEKTURNA HCT TABLET 300-12.5 MG ORAL... 9 TEKTURNA HCT TABLET 300-25 MG ORAL... 9 TEKTURNA TABLET 150 MG ORAL...9 TEKTURNA TABLET 300 MG ORAL...9 TRADJENTA TABLET 5 MG ORAL... 5 trimethobenzamide hcl capsule 300 mg oral... 1 ULORIC TABLET 40 MG ORAL...12 ULORIC TABLET 80 MG ORAL...12 VICTOZA SOLUTION PEN-INJECTOR 18 MG/3ML SUBCUTANEOUS...6 14